{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:42:43Z","timestamp":1759693363255,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008993","name":"Sveu\u010dili\u0161te u Zagrebu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.mehy.2019.109308","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T01:53:46Z","timestamp":1562982826000},"page":"109308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The possible synergistic action of sex hormones and glucagon-like peptide-1 (GLP-1) agonists on body mass decline in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"131","author":[{"given":"T.","family":"Re\u017ei\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Blaslov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Kruljac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Raheli\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vrkljan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.P.","family":"Renar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mehy.2019.109308_b0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000442721","article-title":"European guidelines for management of obesity in adults","volume":"8","author":"Yumuk","year":"2015","journal-title":"Obes Facts"},{"key":"10.1016\/j.mehy.2019.109308_b0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ajcn\/76.4.743","article-title":"Waist circumference and obesity associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds","volume":"76","author":"Zhu","year":"2002","journal-title":"Am J Clin Nutr"},{"unstructured":"Purnell JQ: Definitions, classification and epidemiology of obesity. Endotext (Internet).","key":"10.1016\/j.mehy.2019.109308_b0015"},{"issue":"4","key":"10.1016\/j.mehy.2019.109308_b0020","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting lecture: from the triumvirate to the omnious octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"De Fronzo","year":"2009","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.mehy.2019.109308_b0025","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jech.54.8.596","article-title":"Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults","volume":"54","author":"Resnick","year":"2000","journal-title":"J Epidemiol Commun Health"},{"key":"10.1016\/j.mehy.2019.109308_b0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14779072.6.3.343","article-title":"Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity","volume":"6","author":"Bays","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"unstructured":"https:\/\/www.hzjz.hr\/wp-content\/uploads\/2013\/11\/DM-bilten-2005_2014.pdf.","key":"10.1016\/j.mehy.2019.109308_b0035"},{"issue":"368","key":"10.1016\/j.mehy.2019.109308_b0040","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in Type 2 diabetes","volume":"2006","author":"Drucker","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mehy.2019.109308_b0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/pdi.1775","article-title":"What proportion of patients fail NICE criteria for continuing GLP-1 treatment beyond six months, and why?","volume":"30","author":"Wessels","year":"2013","journal-title":"Pract Diab"},{"issue":"Pt A","key":"10.1016\/j.mehy.2019.109308_b0055","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2016.07.039","article-title":"GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight","volume":"110","author":"Vogel","year":"2016","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.mehy.2019.109308_b0060","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1210\/en.2003-0741","article-title":"Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1\/2 pluripotent cells through an androgen receptor-mediated pathway","volume":"144","author":"Singh","year":"2003","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.mehy.2019.109308_b0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diacare.17.5.405","article-title":"Testosterone concentrations in women and men with NIDDM","volume":"17","author":"Andersson","year":"1994","journal-title":"Diab Care"},{"issue":"4","key":"10.1016\/j.mehy.2019.109308_b0070","first-page":"997","article-title":"Pathogenesis of decreased androgen levels in obese men","volume":"79","author":"Giagulli","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.mehy.2019.109308_b0075","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","volume":"93","author":"Wu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mehy.2019.109308_b0080","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EJE-12-0955","article-title":"Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis","volume":"168","author":"Corona","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.mehy.2019.109308_b0085","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1743-6109.2012.02853.x","article-title":"IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men","volume":"10","author":"Zitzmann","year":"2013","journal-title":"J Sex Med"},{"issue":"10","key":"10.1016\/j.mehy.2019.109308_b0090","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/oby.20407","article-title":"Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss","volume":"21","author":"Saad","year":"2013","journal-title":"Obesity"},{"issue":"8","key":"10.1016\/j.mehy.2019.109308_b0095","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2337\/dc10-0515","article-title":"Sex steroids affect triglyceride handling, glucose-dependent insulinotropic polypeptide, and insulin sensitivity","volume":"33","author":"Lapauw","year":"2010","journal-title":"Diab Care"},{"issue":"6","key":"10.1016\/j.mehy.2019.109308_b0100","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/andr.12099","article-title":"Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism","volume":"3","author":"Giagulli","year":"2015","journal-title":"Andrology"},{"issue":"3","key":"10.1016\/j.mehy.2019.109308_b0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/humupd\/dmw045","article-title":"Ovarian hormones and obesity","volume":"23","author":"Leeners","year":"2017","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.mehy.2019.109308_b0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ajcn\/49.2.252","article-title":"Menstrual cycle and voluntary food intake","volume":"49","author":"Gong","year":"1989","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.mehy.2019.109308_b0120","doi-asserted-by":"crossref","first-page":"R1215","DOI":"10.1152\/ajpregu.00446.2012","article-title":"Sex differences in the physiology of eating","volume":"305","author":"Asarian","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"12","key":"10.1016\/j.mehy.2019.109308_b0125","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/nm.3009","article-title":"Targeted estrogen delivery reverses the metabolic syndrome","volume":"18","author":"Finan","year":"2012","journal-title":"Nat Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719305997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719305997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:16:50Z","timestamp":1759691810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719305997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":23,"alternative-id":["S0306987719305997"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109308","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The possible synergistic action of sex hormones and glucagon-like peptide-1 (GLP-1) agonists on body mass decline in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109308"}}